Summary of Research Articles

This collection contains Summary of Research Articles (SRAs) published in the journal. An SRA is a standalone summary of a source article previously published in an Adis journal, or in a journal from another publisher.

Submit your manuscript to this collection through a participating journal.

Journal

Targeted Oncology

Targeted Oncology is a pragmatic tool for all physicians and scientists committed to oncology and cancer research.

Submit to this journal Submission guidelines

Journal

Advances in Therapy

Advances in Therapy is an international, open choice, peer-reviewed (single-blind), and rapid publication journal.

Submit to this journal Submission guidelines

Journal

Diabetes Therapy

Diabetes Therapy is an international, open access, peer-reviewed (single-blind), and rapid publication journal.

Submit to this journal Submission guidelines

Journal

Ophthalmology and Therapy

Ophthalmology and Therapy is an international, open access, peer-reviewed (single-blind), and rapid publication journal.

Submit to this journal Submission guidelines

Journal

Drugs & Therapy Perspectives

Drugs & Therapy Perspectives supports healthcare professionals working in clinical settings by publishing concise, authoritative review articles to aid drug formulary and treatment...

Submit to this journal Submission guidelines

Journal

Rheumatology and Therapy

Rheumatology and Therapy is an international, open access, peer-reviewed (single-blind), and rapid publication journal, dedicated to the publication of high-quality clinical (all...

Submit to this journal Submission guidelines

Showing 1-19 of 19 articles

Summary of Research: Effects of Adalimumab-adbm Versus Adalimumab Reference Product on Patient-Reported Outcomes in Rheumatoid Arthritis: Results from VOLTAIRE-RA
Vibeke Strand
in Rheumatology and Therapy

Summary of Research Open access 09 August 2024 Pages: 1081 - 1084
Adis summary of research: Omalizumab in severe asthma: effect on oral corticosteroid exposure and remodelling. A randomized open-label parallel study
Yahiya Y. Syed
in Drugs & Therapy Perspectives

Adis Summary of Research 24 July 2024 Pages: 291 - 292
Summary of Research: Cardiovascular and Kidney Outcomes with Finerenone in Patients with Type 2 Diabetes and Chronic Kidney Disease—The FIDELITY Pooled Analysis
Karin Humle
Boris Klanger
Nichole Jefferson
in Diabetes Therapy

Summary of Research Open access 19 July 2024 Pages: 1861 - 1864
Adis summary of research: Matching‑adjusted indirect comparisons of diroximel fumarate, ponesimod, and teriflunomide for relapsing multiple sclerosis
Hannah A. Blair
in Drugs & Therapy Perspectives

Adis Summary of Research 01 July 2024 Pages: 239 - 240
Summary of Research: Cost‑Effectiveness of Faricimab in the Treatment of Diabetic Macular Oedema (DMO): A UK Analysis
Christian Bührer
Thomas Paling
Marloes Bagijn
in Ophthalmology and Therapy

SUMMARY OF RESEARCH Open access 25 June 2024 Pages: 2063 - 2066
Adis summary of research: Safety, tolerability and pharmacokinetics of aripiprazole 2-monthly formulation in patients with schizophrenia or bipolar I disorder
Hannah A. Blair
in Drugs & Therapy Perspectives

Adis Summary of Research 27 June 2024 Pages: 190 - 191
Adis summary of research: A 10-year observational study of the use, acceptability and effectiveness of long-acting paliperidone palmitate: implications for clinical decision making
Yahiya Y. Syed
in Drugs & Therapy Perspectives

Adis Summary of Research 01 July 2024 Pages: 192 - 193
Summary of Research: Efficacy and Safety of the SGLT2 Inhibitor Empagliflozin Versus Placebo and the DPP-4 Inhibitor Linagliptin Versus Placebo in Young People with Type 2 Diabetes (DINAMO): A Multicentre, Randomised, Double-Blind, Parallel Group, Phase 3 Trial
Lori M. Laffel
in Diabetes Therapy

Summary of Research Open access 05 April 2024 Pages: 893 - 896
Adis Summary of Research: Extended‑Release Viloxazine Compared with Atomoxetine for Attention Deficit Hyperactivity Disorder
Yahiya Y. Syed
in Drugs & Therapy Perspectives

Adis Summary of Research 06 May 2024 Pages: 139 - 140
Summary of Research: Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC
Masahiro Tsuboi
Roy S. Herbst
Yi-Long Wu
in Targeted Oncology

Summary of Research Open access 11 March 2024 Pages: 131 - 134
Summary of Research: What Is the True Impact of Cognitive Impairment for People Living with Multiple Sclerosis? A Commentary of Symposium Discussions at the 2020 European Charcot Foundation
Sarah A. Morrow
Paola Kruger
Nektaria Alexandri
in Neurology and Therapy

SUMMARY OF RESEARCH Open access 20 February 2024 Pages: 497 - 499
Summary of Research: An Anti-OX40 Antibody to Treat Moderate-to-Severe Atopic Dermatitis: A Multicentre, Double-Blind, Placebo-Controlled Phase 2b Study
Emma Guttman-Yassky
Eric L. Simpson
Masutaka Furue
in Advances in Therapy

Summary of Research Open access 08 January 2024 Pages: 928 - 931
Summary of Research: Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial
Alan Menter
in Dermatology and Therapy

Summary of Research Open access 24 October 2023 Pages: 2929 - 2932
Summary of Research: Adjuvant Nivolumab Plus Ipilimumab Versus Placebo for Localized Renal Cell Carcinoma After Nephrectomy (CheckMate 914): A Double-Blind, Randomized, Phase 3 Trial
Robert J. Motzer
Paul Russo
Axel Bex
in Targeted Oncology

Summary of research Open access 02 September 2023 Pages: 639 - 641
Adis Summary of Research: Safety, Effectiveness, and Immunogenicity 6 Months After BNT162B2 mRNA Vaccine in Frail Nursing Home Residents
Julia Paik
Zaina T. Al-Salama
in Drugs & Therapy Perspectives

Adis Summary of Research 29 July 2023 Pages: 317 - 318
Summary of Research: Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia Gravis
Tuan Vu
Andreas Meisel
James F. Howard Jr.
in Neurology and Therapy

Summary of Research Open access 23 June 2023 Pages: 1435 - 1438
Summary of Research: Caregiver Involvement in MS: Duty or Disruption?
Jürg Kesselring
Alexey Boyko
Nektaria Alexandri
in Neurology and Therapy

SUMMARY OF RESEARCH Open access 21 June 2023 Pages: 1431 - 1434
Summary of Research: Development and Validation of the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ)
Stacie Hudgens
Andrea Phillips-Beyer
Heike Benes
in Advances in Therapy

Summary of Research Open access 26 April 2023 Pages: 2573 - 2576
Adis Summary of Research: Effect of FT218, a Once-Nightly Sodium Oxybate Formulation, on Disrupted Nighttime Sleep in Patients with Narcolepsy: Results from the Randomized Phase III REST-ON Trial
Julia Paik
in Drugs & Therapy Perspectives

Adis Summary of Research 25 April 2023 Pages: 165 - 166

Summary of Research Articles

Participating journals

Targeted Oncology

Advances in Therapy

Diabetes Therapy

Ophthalmology and Therapy

Drugs & Therapy Perspectives

Rheumatology and Therapy

Articles

Summary of Research: Effects of Adalimumab-adbm Versus Adalimumab Reference Product on Patient-Reported Outcomes in Rheumatoid Arthritis: Results from VOLTAIRE-RA

Adis summary of research: Omalizumab in severe asthma: effect on oral corticosteroid exposure and remodelling. A randomized open-label parallel study

Summary of Research: Cardiovascular and Kidney Outcomes with Finerenone in Patients with Type 2 Diabetes and Chronic Kidney Disease—The FIDELITY Pooled Analysis

Adis summary of research: Matching‑adjusted indirect comparisons of diroximel fumarate, ponesimod, and teriflunomide for relapsing multiple sclerosis

Summary of Research: Cost‑Effectiveness of Faricimab in the Treatment of Diabetic Macular Oedema (DMO): A UK Analysis

Adis summary of research: Safety, tolerability and pharmacokinetics of aripiprazole 2-monthly formulation in patients with schizophrenia or bipolar I disorder

Adis summary of research: A 10-year observational study of the use, acceptability and effectiveness of long-acting paliperidone palmitate: implications for clinical decision making

Summary of Research: Efficacy and Safety of the SGLT2 Inhibitor Empagliflozin Versus Placebo and the DPP-4 Inhibitor Linagliptin Versus Placebo in Young People with Type 2 Diabetes (DINAMO): A Multicentre, Randomised, Double-Blind, Parallel Group, Phase 3 Trial

Adis Summary of Research: Extended‑Release Viloxazine Compared with Atomoxetine for Attention Deficit Hyperactivity Disorder

Summary of Research: Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC

Summary of Research: What Is the True Impact of Cognitive Impairment for People Living with Multiple Sclerosis? A Commentary of Symposium Discussions at the 2020 European Charcot Foundation

Summary of Research: An Anti-OX40 Antibody to Treat Moderate-to-Severe Atopic Dermatitis: A Multicentre, Double-Blind, Placebo-Controlled Phase 2b Study

Summary of Research: Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial

Summary of Research: Adjuvant Nivolumab Plus Ipilimumab Versus Placebo for Localized Renal Cell Carcinoma After Nephrectomy (CheckMate 914): A Double-Blind, Randomized, Phase 3 Trial

Adis Summary of Research: Safety, Effectiveness, and Immunogenicity 6 Months After BNT162B2 mRNA Vaccine in Frail Nursing Home Residents

Summary of Research: Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia Gravis

Summary of Research: Caregiver Involvement in MS: Duty or Disruption?

Summary of Research: Development and Validation of the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ)

Adis Summary of Research: Effect of FT218, a Once-Nightly Sodium Oxybate Formulation, on Disrupted Nighttime Sleep in Patients with Narcolepsy: Results from the Randomized Phase III REST-ON Trial

Navigation

Summary of Research Articles

Participating journals

Articles

Search

Navigation